[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-345319-105":59,"doc-detail-345319-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","multi-omics-characterization-of-abhd12-across-pan-cancer-and-validation-of-its-role-in-promoting-proliferation-and-metastasis-in-breast-cancer-original-research","Multi-Omics Characterization of ABHD12 Across Pan-Cancer and Validation of Its Role in Promoting Proliferation and Metastasis in Breast Cancer - Original Research","","Original research investigates ABHD12, a lipid-metabolism regulator, across pan-cancer profiles and validates its oncogenic function in breast cancer. Multi-omics integration from TCGA, GTEx, and public platforms assesses expression, prognosis, genetic variation, methylation, immune infiltration, and drug resistance. qRT-PCR, Western blot, functional assays, and nude mouse xenografts confirm elevated ABHD12 in multiple cancers and a poorer survival association in key breast and brain cancers. Findings connect ABHD12 with CNV-driven dysregulation, AMPK pathway signaling, macrophage-linked microenvironment remodeling, and resistance to multiple chemotherapeutics.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/multi-omics-characterization-of-abhd12-across-pan-cancer-and-validation-of-its-role-in-promoting-proliferation-and-metastasis-in-breast-cancer-original-research/345319/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/multi-omics-characterization-of-abhd12-across-pan-cancer-and-validation-of-its-role-in-promoting-proliferation-and-metastasis-in-breast-cancer-original-research/345319.png","ImageObject",300,407,{"name":92,"@type":93},"Oliver","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What was the purpose of this study on ABHD12?","Question",{"text":113,"@type":114},"The study systematically characterized ABHD12’s pan-cancer role and validated its oncogenic function in breast cancer to support mechanistic research.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Which methods and data sources were used to evaluate ABHD12?",{"text":118,"@type":114},"The work integrated multi-omics data from TCGA, GTEx, and public platforms, and validated findings using qRT-PCR, Western blot, functional assays, and a nude mouse xenograft model.",{"name":120,"@type":111,"acceptedAnswer":121},"What key findings link ABHD12 to cancer progression?",{"text":122,"@type":114},"ABHD12 was upregulated across multiple cancers, associated with worse survival in several cancers (including BRCA), and connected to CNVs, immune infiltration patterns, AMPK pathway activity, and chemotherapy resistance.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},345319,1790568955,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":26,"preview_page_count":19,"preview_urls":146},8796095461610,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Breast Cancer: Targets and Therapy  \n Open Access Full Text Article  \nORIGINAL RESEARCH  \nMulti-Omics Characterization of ABHD12 Across Pan-Cancer and Validation of Its Role in Promoting Proliferation and Metastasis in Breast Cancer  \nJiawei Zhao 1 , *, Yuting Gou 1 , *, Yiyang Wang 1 , *, Yongxiang Li 1 , Haotian Ma 1 , Yiting Xing2 , Haohao Peng2 , Chenming Guo 1 , 3  \n1Department of Breast Surgery, Center of Digestive and Vascular, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, People’s Republic of China; 2Department of Clinical Medicine, Xinjiang Medical University, Urumqi, People’s Republic of China; 3State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, People’s Republic of China  \n*These authors contributed equally to this work  \nCorrespondence: Chenming Guo, [Email gcm_xjmu@yeah.net](Email gcm_xjmu@yeah.net)  \n\n| Purpose: ABHD12 is linked to cancer and neurodegeneration; we systematically characterized its pan-cancer role and validated its oncogenic function in breast cancer (BRCA) to guide mechanistic studies.\u003Cbr>Methods: We integrated multi-omics data from TCGA, GTEx, and various public platforms to analyze expression, prognosis, genetic variations, methylation, immune infiltration, and drug resistance. In qRT-PCR, Western blot, functional assays (CCK-8, wound healing, colony formation), and a nude mouse xenograft model, were conducted to validate ABHD12’s role in BRCA.\u003Cbr>Results: ABHD12 was significantly upregulated at both mRNA and protein levels across multiple cancers. High expression correlated with poorer overall survival in BRCA, GBM, LGG, LIHC, and UVM. It demonstrated strong to moderate diagnostic value. ABHD12 expression was associated with copy number variations (CNVs) across 23 cancers, but not with methylation. It also correlated with immune cell infiltration (especially with macrophage), tumor mutational burden, neoantigens, microsatellite instability, and immunerelated genes in certain cancers, and was potentially linked to resistance to multiple chemotherapeutics. KEGG analysis indicated that ABHD12 may play a potential role in the AMPK pathway. In BRCA, ABHD12 was higher in tumors than normal tissues. Functional studies showed ABHD12 enhanced proliferation, invasion, and migration, while silencing suppressed these traits. In vivo, ABHD12-overexpressing cells formed larger tumors, confirming its tumor-promoting role.\u003Cbr>Conclusion: ABHD12 may act as an oncogene across multiple cancers, linked to poor prognosis, diagnostic potential, chemotherapy resistance, and immunotherapy response. Its dysregulation is driven by CNVs rather than promoter methylation. ABHD12 might modulate macrophage polarization via the AMPK signaling pathway, leading to the remodeling of the tumor immune microenvironment. In vitro and vivo studies confirm its pro-tumorigenic role in BRCA, highlighting ABHD12 as a multifunctional biomarker anda molecular nexus linking lipid metabolism, immunity, and treatment resistance—warranting further study.\u003Cbr>Keywords: ABHD12, pan-cancer, prognosis, tumor immunity, drug resistance |\n| --- |\n| Introduction\u003Cbr>Globally, cancerous neoplasms are the second reason for death. Based on the 2022 GLOBOCAN estimates, the global count of new cancer cases exceeded 18 million, with nearly 10 million deaths attributed to cancer.1 Given this substantial disease burden, elucidating the key molecular mechanisms driving tumorigenesis and progression has become an urgent priority for the advancement of precise approaches for diagnostics and therapeutics. Emerging evidence highlights that tumor cells undergo metabolic reprogramming, particularly in lipid metabolism, to meet the heightened demands for energy, membrane synthesis, and signal transduction required for rapid proliferation and metastasis.2 The α/β-hydrolase |\n\n[https://doi.org/10.2147/BCTT.S554836](https://","cbCaid870nryKsBs","https://ap.wps.com/l/cbCaid870nryKsBs","pdf",20938601,24,"English","# Purpose\n# Methods\n# Results\n# Conclusion\n# Introduction","[{\"question\":\"What was the purpose of this study on ABHD12?\",\"answer\":\"The study systematically characterized ABHD12’s pan-cancer role and validated its oncogenic function in breast cancer to support mechanistic research.\"},{\"question\":\"Which methods and data sources were used to evaluate ABHD12?\",\"answer\":\"The work integrated multi-omics data from TCGA, GTEx, and public platforms, and validated findings using qRT-PCR, Western blot, functional assays, and a nude mouse xenograft model.\"},{\"question\":\"What key findings link ABHD12 to cancer progression?\",\"answer\":\"ABHD12 was upregulated across multiple cancers, associated with worse survival in several cancers (including BRCA), and connected to CNVs, immune infiltration patterns, AMPK pathway activity, and chemotherapy resistance.\"}]","Multi-Omics Characterization of ABHD12 Across Pan-Cancer and Validation of Its Role in Promoting Proliferation and Metastasis in Breast Cancer - Original Research | PDF",1790057280,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4ced34cce578ae26c8f28dee2a61dc93.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7962eb406717115333f6cc94d91eadf8.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4534f6e416be36d404c33944d5b2d237.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5a19e022512ba9c782f79b0cdb7eba2d.webp",980,1268]